Search for:

In brief

On 4 May 2021, the official Italian version of the European Medical Device Nomenclature (EMDN), to be used for the registration of medical devices in the Eudamed database, was published. The EMDN has been developed on the basis of the Italian National Classification of Medical Devices due to its characteristics in terms of structure, purpose, usability and updating methodology.


What’s new

As the EMDN primarily serves regulatory purposes to meet the requirements of the EU Regulations on medical devices and in vitro diagnostics, it also plays a key role, for example, in the preparation of the technical documentation for devices, in the sampling of the same documentation by notified bodies as well as in the post-market review and analysis of data. In addition, it provides the description of devices used and of those available on the market and registered in Eudamed.

In this regard, it should be noted that the English version of the EMDN is still in the process of being finalized and that a consultation on the relevant draft, ended on 4 June, has been carried out to collect suggestions on the syntax or reports of possible translation errors from the healthcare community. The final English version is expected to be published in the third quarter of 2021.

Author

Roberto Cursano has been a lawyer in Baker McKenzie since September 2007. He focuses on healthcare law and compliance, and assists in tender procedures, the negotiation of public contracts and litigation before administrative courts. Mr. Cursano is a former administrative officer in the Italian Ministry of Health and helps clients work closely with the Italian Public Administration. He is admitted to the bar before the Italian Supreme Court and the Council of State. As well as training and tutoring in the master’s degree program on clinical trials of pharmaceutical products at the University of Rome Sapienza, Mr. Cursano regularly publishes articles and scientific contributions. He also frequently hosts and participates in seminars and presentations on pharmaceutical and administrative law matters.

Author

Riccardo Ovidi is an Associate in Baker McKenzie Rome office.

Write A Comment